Literature DB >> 34269189

Delving into the recent advancements of spinal cord injury treatment: a review of recent progress.

Joseph A Flack1, Krishna Deo Sharma2, Jennifer Yanhua Xie1.   

Abstract

Spinal cord injury (SCI) research is a very complex field lending to why reviews of SCI literatures can be beneficial to current and future researchers. This review focuses on recent articles regarding potential modalities for the treatment and management of SCI. The modalities were broken down into four categories: neuroprotection-pharmacologic, neuroprotection-non-pharmacologic, neuroregeneration-pharmacologic, neuroregeneration-non-pharmacologic. Peer-reviewed articles were found using PubMed with search terms: "spinal cord injury", "spinal cord injury neuroregeneration", "olfactory ensheathing cells spinal cord injury", "rho-rock inhibitors spinal cord injury", "neural stem cell", "scaffold", "neural stem cell transplantation", "exosomes and SCI", "epidural stimulation SCI", "brain-computer interfaces and SCI". Most recent articles spanning two years were chosen for their relevance to the categories of SCI management and treatment. There has been a plethora of pre-clinical studies completed with their results being difficult to replicate in clinical studies. Therefore, scientists should focus on understanding and applying the results of previous research to develop more efficacious preclinical studies and clinical trials.

Entities:  

Keywords:  brain-computer interface; epidural stimulation; exosomes; neuroprotection; neuroregeneration; scaffolds; spinal cord injury management; stem cells; transplantation

Year:  2022        PMID: 34269189     DOI: 10.4103/1673-5374.317961

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   5.135


  8 in total

1.  The human dental apical papilla promotes spinal cord repair through a paracrine mechanism.

Authors:  P De Berdt; K Vanvarenberg; B Ucakar; C Bouzin; A Paquot; V Gratpain; A Loriot; V Payen; B Bearzatto; G G Muccioli; L Gatto; A Diogenes; A des Rieux
Journal:  Cell Mol Life Sci       Date:  2022-04-21       Impact factor: 9.261

Review 2.  [Advances of the role of mitochondrial dysfunction in the spinal cord injury and its relevant treatments].

Authors:  Xin Miao; Junqing Lin; Xianyou Zheng
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-07-15

3.  Reduced Muscle Activity of the Upper Extremity in Individuals with Spinal Cord Injuries.

Authors:  Kyung-Sun Lee; Mobasshira Zaman; Jaejin Hwang
Journal:  Int J Environ Res Public Health       Date:  2022-04-13       Impact factor: 4.614

4.  Quantitative iTRAQ proteomics reveal the proteome profiles of bone marrow mesenchymal stem cells after cocultures with Schwann cells in vitro.

Authors:  Han Ding; Ang Li; Chao Sun; Jianping Zhang; Jun Shang; Haoshuai Tang; Junjin Li; Min Wang; Xiaohong Kong; Zhijian Wei; Shiqing Feng
Journal:  Ann Transl Med       Date:  2022-09

Review 5.  Specific microRNAs for Modulation of Autophagy in Spinal Cord Injury.

Authors:  Rhett Visintin; Swapan K Ray
Journal:  Brain Sci       Date:  2022-02-11

Review 6.  The immune microenvironment and tissue engineering strategies for spinal cord regeneration.

Authors:  Yuan Feng; Yong Peng; Jing Jie; Yumin Yang; Pengxiang Yang
Journal:  Front Cell Neurosci       Date:  2022-08-04       Impact factor: 6.147

Review 7.  Biomaterial-Mediated Factor Delivery for Spinal Cord Injury Treatment.

Authors:  Filippo Pinelli; Fabio Pizzetti; Valeria Veneruso; Emilia Petillo; Michael Raghunath; Giuseppe Perale; Pietro Veglianese; Filippo Rossi
Journal:  Biomedicines       Date:  2022-07-12

8.  Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials.

Authors:  Zhizhong Shang; Mingchuan Wang; Baolin Zhang; Xin Wang; Pingping Wanyan
Journal:  BMC Med       Date:  2022-09-05       Impact factor: 11.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.